Details of the Drug Reposition

General Information of This Drug (ID: DM6URNJ)

Drug Name	JNJ-67856633 DM6URNJ

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Chronic lymphocytic leukaemia	DISEXWC3	2A82.0	Phase 1	[1]
Non-hodgkin lymphoma	DISS2Y8A	2B33.5	Phase 1	[1]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03900598) A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL). U.S. National Institutes of Health.